Inhibitory Activities of Gatifloxacin (AM-1155), a Newly Developed Fluoroquinolone, against Bacterial and Mammalian Type II Topoisomerases

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Antimicrob Agents Chemother
Prif Awduron: Takei, Masaya, Fukuda, Hideyuki, Yasue, Tokutaro, Hosaka, Masaki, Oomori, Yasuo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology (ASM) 1998
Pynciau:
Mechanisms of Action: Physiological Effects
Mynediad Ar-lein:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105918/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9756776/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.10.2678
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg